Year To Quarter End Consolidated Statement Of Income

Immuno-Biological Laboratories Co., Ltd. - Filing #7295281

Concept 2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
Year to quarter end consolidated statement of income
Statement of income
Net sales
441,150,000 JPY
2,977,000 JPY
444,127,000 JPY
444,127,000 JPY
JPY
2,106,000 JPY
363,410,000 JPY
365,516,000 JPY
JPY
365,516,000 JPY
Cost of sales
164,149,000 JPY
150,762,000 JPY
Gross profit (loss)
279,977,000 JPY
214,753,000 JPY
Selling, general and administrative expenses
Selling, general and administrative expenses
211,975,000 JPY
201,453,000 JPY
Operating profit (loss)
67,279,000 JPY
723,000 JPY
68,002,000 JPY
68,002,000 JPY
JPY
-3,079,000 JPY
16,379,000 JPY
13,300,000 JPY
JPY
13,300,000 JPY
Non-operating income
Interest income
91,000 JPY
47,000 JPY
Non-operating income
2,448,000 JPY
17,915,000 JPY
Non-operating expenses
Interest expenses
619,000 JPY
533,000 JPY
Non-operating expenses
6,240,000 JPY
576,000 JPY
Ordinary profit (loss)
64,211,000 JPY
30,639,000 JPY
Extraordinary losses
Impairment losses
JPY
602,000 JPY
Extraordinary losses
JPY
769,000 JPY
Profit (loss) before income taxes
64,211,000 JPY
29,869,000 JPY
Income taxes - current
617,000 JPY
3,007,000 JPY
Income taxes - deferred
-7,918,000 JPY
JPY
Income taxes
-7,300,000 JPY
3,007,000 JPY
Profit (loss)
71,512,000 JPY
26,861,000 JPY
Profit attributable to
Profit (loss) attributable to owners of parent
71,512,000 JPY
26,861,000 JPY
Comprehensive income
71,512,000 JPY
26,861,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
71,512,000 JPY
26,861,000 JPY
Comprehensive income attributable to non-controlling interests
JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.